| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 6.27B | 6.27B | 6.22B | 6.34B | 6.50B | 7.52B |
| Gross Profit | 3.16B | 3.22B | 3.10B | 3.01B | 3.07B | 3.95B |
| EBITDA | 689.50M | 860.30M | 601.23M | 610.95M | 346.77M | 1.27B |
| Net Income | 124.20M | 234.67M | 116.37M | 45.72M | -158.75M | 548.35M |
Balance Sheet | ||||||
| Total Assets | 6.08B | 5.65B | 5.64B | 5.85B | 6.81B | 7.28B |
| Cash, Cash Equivalents and Short-Term Investments | 1.34B | 1.27B | 794.45M | 555.29M | 621.86M | 970.52M |
| Total Debt | 685.58M | 563.65M | 558.85M | 660.87M | 677.59M | 335.74M |
| Total Liabilities | 2.81B | 2.47B | 2.52B | 2.75B | 3.24B | 3.32B |
| Stockholders Equity | 3.16B | 3.08B | 3.00B | 2.98B | 3.26B | 3.62B |
Cash Flow | ||||||
| Free Cash Flow | 681.26M | 734.33M | 644.25M | 314.88M | -285.12M | 609.90M |
| Operating Cash Flow | 824.07M | 859.02M | 790.54M | 502.36M | 124.39M | 1.26B |
| Investing Cash Flow | -131.92M | 65.89M | -294.29M | -189.16M | -400.26M | -636.70M |
| Financing Cash Flow | -71.81M | -298.24M | -403.49M | -366.25M | -84.83M | -552.41M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | HK$11.66B | 14.57 | 16.58% | 6.12% | 1.10% | -7.88% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | HK$14.46B | 39.10 | 5.56% | 2.27% | ― | ― | |
58 Neutral | HK$7.51B | ― | -4.66% | 1.95% | -2.15% | -202.71% | |
58 Neutral | HK$6.95B | 36.88 | 5.18% | 1.44% | 7.44% | -42.52% | |
58 Neutral | HK$7.61B | 11.67 | 6.29% | ― | 100.45% | 2.89% | |
57 Neutral | HK$7.78B | 33.84 | 7.71% | 1.91% | 0.91% | 101.66% |
Vitasoy International Holdings has outlined the terms of reference for its Remuneration and Nomination Committee, emphasizing the importance of independent non-executive directors in its governance structure. The committee is tasked with overseeing the remuneration policies for directors and senior management, ensuring alignment with the company’s strategic goals and promoting long-term success. This move is aimed at enhancing transparency and accountability in the company’s remuneration practices, potentially impacting its operational efficiency and stakeholder trust.
The most recent analyst rating on (HK:0345) stock is a Hold with a HK$10.00 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.
Vitasoy International Holdings has outlined the terms of reference for its Audit Committee, emphasizing the importance of independent oversight in its governance structure. The committee will be composed of non-executive directors, primarily independent ones, and will focus on financial reporting, internal control, and risk management. This move is likely to enhance the company’s transparency and accountability, potentially strengthening its position in the market and reassuring stakeholders of its commitment to robust governance practices.
The most recent analyst rating on (HK:0345) stock is a Hold with a HK$10.00 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.
Vitasoy International Holdings has outlined the terms of reference for its Remuneration and Nomination Committee. The committee, primarily composed of Independent Non-executive Directors, is tasked with overseeing the remuneration policies and structures for the company’s directors and senior management. This includes ensuring that remuneration aligns with the company’s culture, risk appetite, and long-term strategic goals, and that a significant portion of remuneration is linked to corporate and individual performance. The committee’s responsibilities also extend to reviewing and approving performance-related pay schemes and employee share schemes, ensuring transparency and alignment with corporate objectives.
The most recent analyst rating on (HK:0345) stock is a Hold with a HK$10.00 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.
Vitasoy International Holdings Limited announced the successful passing of all proposed resolutions during its Annual General Meeting held on August 25, 2025. The resolutions included the adoption of financial statements, approval of a final dividend, re-election of directors, and amendments to the Articles of Association, reflecting strong shareholder support and strategic governance decisions.
The most recent analyst rating on (HK:0345) stock is a Hold with a HK$10.00 price target. To see the full list of analyst forecasts on Vitasoy International Holdings stock, see the HK:0345 Stock Forecast page.